Blue Cross spent $515 million on GLP-1 drugs last year and was on track to nearly double that spending before changing its coverage policy
NEVER Freeze the Liquid: While freezing the powder is good, freezing the liquid solution is bad
This isnt just Oracles challenge, its every healthtech innovators
The investigation specifically showed that these drugs did not increase the risk of any fractures, confirming their safety profile in clinical practice ( 4.6 Ophthalmological effects 4.6.1 Glaucoma GLP-1R agonists exhibit anti-inflammatory and neuroprotective properties, suggesting they could also be beneficial in neurodegenerative diseases ( A recent registry-based case-control study, summarized in Table 2 , involving 1,961 patients found that the use of GLP-1R agonists is linked to a lower risk of glaucoma (Sterling et al., 2021 ( Table 2 Clinical studies elucidating the use of antidiabetics against glaucoma
Taken together, these dynamics combined with favorable demographics and rising disposable incomes position Asia Pacific as the most critical long-term growth hub for the yerba mate market expansion